CIBC Private Wealth Group
KZR

CIBC Private Wealth Group’s Kezar Life Sciences KZR Stock Holding History

CIBC Private Wealth Group’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$629 Hold
100
– – ﹤0.01% 3000
2025
Q3 		$390 Hold
100
– – ﹤0.01% 2900
2025
Q2 		$458 Hold
100
– – ﹤0.01% 2848
2025
Q1 		$402 Buy
+100
New +$607 ﹤0.01% 2910
2024
Q4 		– Sell
-100
Closed -$773 – 3088
2024
Q3 		$773 Hold
100
– – ﹤0.01% 2937
2024
Q2 		$547 Hold
100
– – ﹤0.01% 2966
2024
Q1 		$920 Buy
+100
New +$911 ﹤0.01% 2873

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

CIBC Private Wealth Group's KZR Position: Q4 2025 in Review

CIBC Private Wealth Group held its Kezar Life Sciences (KZR) position steady in Q4 2025 at 100 shares worth $629. The position accounts for ﹤0.01% of the portfolio, ranked #3000.

CIBC Private Wealth Group first reported a position in KZR in Q1 2024 and has held it in 7 quarters since. The position peaked at $920 in Q1 2024. 43 funds tracked by Wall St. Rank hold KZR as of Q4 2025.

  • CIBC Private Wealth Group held 100 shares of Kezar Life Sciences worth $629 as of Q4 2025.
  • CIBC Private Wealth Group left its Kezar Life Sciences share count unchanged in Q4 2025.
  • Kezar Life Sciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3000 holding.
  • CIBC Private Wealth Group first reported a position in Kezar Life Sciences in Q1 2024 and has held it in 7 quarters since.
  • CIBC Private Wealth Group's Kezar Life Sciences position peaked at $920 in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.